Concepts
3 Results
- Concept
The Anti Snake Venom Crisis in Africa: A Suggested Manufacturers Product Guide
Wilderness & Environmental MedicineVol. 20Issue 3p275–282Published in issue: September, 2009- Ian D. Simpson
- Roger S.M. Blaylock
Cited in Scopus: 10Considerable attention has been given to the shortage of anti snake venom in Africa. The current supply is reported to rest at crisis levels, and considerable attention has been given to reporting the crisis. What has been absent is a recommended list of anti snake venoms that suppliers can produce in order to alleviate the problem. Suppliers who may want to enter the market and provide new anti snake venoms are hampered by a lack of knowledge of which to provide, where to source the venoms necessary for production, and the likely volume levels required. - Concepts
Antisnake Venom Production Crisis—Who Told Us It Was Uneconomic and Unsustainable?
Wilderness & Environmental MedicineVol. 20Issue 2p144–155Published in issue: June, 2009- Ian D. Simpson
- Ingrid M. Jacobsen
Cited in Scopus: 8The world of antisnake venom production is currently a gloomy place to visit. It is described as being in crisis, characterized by shortages, producers leaving the market, high prices, and unsustainability. It has been reduced to a pauper-like status, doomed to relying on chari\ handouts for resolution. The worrying aspect of this is that little work has been done to establish the true economics and return on antisnake venom if provided by private companies. Fortunately, it is amenable to economic analysis, and in this manner, a rational approach to further development and distribution can be obtained. - Concepts
The Global Snakebite Crisis—A Public Health Issue Misunderstood, Not Neglected
Wilderness & Environmental MedicineVol. 20Issue 1p43–56Published in issue: March, 2009- Ian D. Simpson
- Robert L. Norris
Cited in Scopus: 25The global problem of venomous snakebite continues to attract attention despite it being described as a “neglected” issue. The current focus of the World Health Organization (WHO) remains anti– snake venom quality, although “availability and sustainability” of supply are consistently described as the key issues. Sustainability of antivenom supply has been elusive, with cost and pricing in developing countries being cited as the major reasons. The current WHO approach fails to explore the cost issue, but rather focuses on quality improvements, which may well adversely affect the costs of a product already perceived to be ‘unaffordable.’ The reference to cost and price indicates a marketing-based perspective may well give more relevant solutions to the snakebite crisis.